Research programme: oxazolidinones - AstraZeneca
Alternative Names: Compound 26 (prodrug) - AstraZeneca; Isoxazolino-oxazolidinones - AstraZeneca; Oxazolidinone prodrugs - AstraZenecaLatest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator AstraZeneca
- Class Oxazolidinones
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in United Kingdom
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in USA
- 28 Sep 2007 Preclinical development is ongoing